Table of Contents Table of Contents
Previous Page  108 / 242 Next Page
Show Menu
Previous Page 108 / 242 Next Page
Page Background

108

Chapter 8

Perioperative use

Dexmedetomidine has the potential to gain a place in the perioperative setting. Its sedative,

analgesic, and anxiolytic effects make it a suitable agent for premedication.

An anticipated difficult airway necessitates an awake fiberoptic intubation. To minimise

stressful moments for the patient, sedation offers a most welcome support. However, it is

important to keep the patient cooperative and spontaneously breathing. Dexmedetomidine

can meet this requirement in contrast to other sedatives and additionally provide a

reduction of salivation.

During awake craniotomies an active participation of the patient in surgery is necessary and

expected. Tanskanen et al.

10

showed that awakening, extubation, and obtaining of adequate

spontaneous breathing is reached more quickly with dexmedetomidine in comparison

with fentanyl. Patients indeed were sedated but respond adequately.

During the postoperative phase, dexmedetomidine can reduce the necessary amount of

opioids. Especially with patients at risk for a compromised airway, dexmedetomidine may

play an important role.

Procedural Sedation

The demand for sedation support during minimal invasive procedures is continuously

growing. Most hospitals have specific protocols for sedation during colonoscopies,

gastroscopies, and ERCP’s. Medication varies from midazolam to propofol, often combined

with an opiate; sedation is often administered by specially trained anaesthesia nurses for

procedural sedation (PSA). The on-going question is whether dexmedetomidine also could

play a role in procedural sedation.

Till now, a number of small studies had been performed studying endoscopist`s and

patients satisfaction. For sedation during procedures that are unpleasant but not painful,

dexmedetomidine certainly has a value. Patients are more cooperative, less retching, and

afterwards just as satisfied as patients who received midazolam. Also, the endoscopist is

more satisfied with patients of the dexmedetomidine group.

11

Painful procedures such as

colonoscopies often necessitate opiates as rescue medication and longer recovery times

due to hypotension and bradycardia. In addition, for the acute colic pain during ERCP’s,

dexmedetomidine has not sufficient analgesic effect. The same is shown in healthy

volunteers: dexmedetomidine has no effect on experimental acute pain.

12

Future

For paediatric sedation, dexmedetomidine is still used off-label. Nevertheless, it seems

to be a welcome addition to standard used sedatives. During MRI, children sedated with

dexmedetomidine remained calmer compared to midazolam, and recovered faster in